Medigen Biotechnology Strategic Asset Allocation Index
Medigen Biotechnology strategic asset allocation index. Medigen Biotechnology (3176) has a Strategic Asset Allocation Index of 37.1% as of June 2023. Strategic assets (PP&E of NT$2.15 Billion plus long-term investments of NT$-) total NT$2.15 Billion, measured against net assets of NT$5.80 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 3176 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Medigen Biotechnology (2003–2021)
Strategic asset allocation index of Medigen Biotechnology from 2003 to 2021. This chart shows how Medigen Biotechnology's Strategic Asset Allocation Index has evolved across 19 annual periods from 2003 to 2021. As of June 2023, the index stands at 37.1%, representing strategic assets of NT$2.15 Billion against net assets of NT$5.80 Billion TWD. Check Medigen Biotechnology tangible equity quality to evaluate the tangible quality of the company's equity base.
Medigen Biotechnology Strategic Asset Allocation Index by Year (2003–2021)
Medigen Biotechnology strategic asset allocation index by year from 2003 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Medigen Biotechnology from 2003 to 2021, covering 19 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 3176 market cap.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 34.1% | NT$2.19 Billion | NT$2.19 Billion | NT$- | NT$6.43 Billion | ▼ -14.1 pp |
| 2020 | 48.1% | NT$2.17 Billion | NT$2.17 Billion | NT$- | NT$4.50 Billion | ▼ -46.5 pp |
| 2019 | 94.6% | NT$2.54 Billion | NT$2.54 Billion | NT$- | NT$2.69 Billion | ▲ +17.7 pp |
| 2018 | 76.9% | NT$2.26 Billion | NT$2.23 Billion | NT$26.93 Million | NT$2.94 Billion | ▲ +2.3 pp |
| 2017 | 74.6% | NT$2.37 Billion | NT$2.35 Billion | NT$19.56 Million | NT$3.18 Billion | ▲ +6.7 pp |
| 2016 | 67.9% | NT$2.40 Billion | NT$2.38 Billion | NT$28.05 Million | NT$3.54 Billion | ▲ +10.5 pp |
| 2015 | 57.4% | NT$1.99 Billion | NT$1.91 Billion | NT$76.67 Million | NT$3.46 Billion | ▲ +16.8 pp |
| 2014 | 40.6% | NT$1.49 Billion | NT$1.49 Billion | NT$- | NT$3.66 Billion | ▲ +22.1 pp |
| 2013 | 18.6% | NT$570.28 Million | NT$570.28 Million | NT$- | NT$3.07 Billion | ▲ +9.8 pp |
| 2012 | 8.8% | NT$179.79 Million | NT$179.79 Million | NT$- | NT$2.05 Billion | ▼ -0.8 pp |
| 2011 | 9.6% | NT$87.73 Million | NT$87.73 Million | NT$- | NT$915.79 Million | ▼ -0.1 pp |
| 2010 | 9.7% | NT$78.30 Million | NT$78.30 Million | NT$- | NT$807.90 Million | ▼ -1.2 pp |
| 2009 | 10.9% | NT$65.00 Million | NT$65.00 Million | NT$- | NT$597.02 Million | ▲ +1.5 pp |
| 2008 | 9.4% | NT$50.87 Million | NT$50.87 Million | NT$- | NT$539.65 Million | ▲ +6.7 pp |
| 2007 | 2.7% | NT$12.85 Million | NT$12.85 Million | NT$- | NT$468.68 Million | ▲ +1.1 pp |
| 2006 | 1.6% | NT$10.71 Million | NT$10.71 Million | NT$- | NT$667.93 Million | ▲ +0.7 pp |
| 2005 | 0.9% | NT$5.60 Million | NT$5.60 Million | NT$- | NT$650.39 Million | ▼ -0.2 pp |
| 2004 | 1.1% | NT$7.92 Million | NT$7.92 Million | NT$- | NT$739.26 Million | ▼ -0.6 pp |
| 2003 | 1.6% | NT$13.92 Million | NT$13.92 Million | NT$- | NT$856.65 Million | — |